FDA Inspection
Vetter Pharma Fertigung GmbH & Co. KGVetter Pharma Fertigung GmbH & Co. KG – FDA Inspection, Nov 10, 2017
Record Details
This FDA Inspection record concerns Vetter Pharma Fertigung GmbH & Co. KG, with an inspection on November 10, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 968de51c-e214-44f7-a385-ef47b0ee884f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1031350
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of Vetter Pharma Fertigung GmbH & Co. KG
9| Date | Classification | Office | Project area |
|---|---|---|---|
| April 24, 2024 | Not classified | Office of Inspections and Investigations | |
| February 24, 2023 | Not classified | Office of Inspections and Investigations | |
| May 24, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 13, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 21, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Vetter Pharma Fertigung GmbH & Co. KG
- FDA Inspection 1234265 - 2024-04-24
- FDA Inspection 1201723 - 2023-02-24
- FDA Inspection 1205983 - 2022-05-24
- FDA Inspection 1129699 - 2019-09-13
- FDA Inspection 1070717 - 2018-09-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.